RamÃrez-Tortosa, C.L.; Alonso-Calderón, R.; Gálvez-Navas, J.M.; Pérez-RamÃrez, C.; Quiles, J.L.; Sánchez-Rovira, P.; Jiménez-Morales, A.; RamÃrez-Tortosa, M.
Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancers 2022, 14, 5393.
https://doi.org/10.3390/cancers14215393
AMA Style
RamÃrez-Tortosa CL, Alonso-Calderón R, Gálvez-Navas JM, Pérez-RamÃrez C, Quiles JL, Sánchez-Rovira P, Jiménez-Morales A, RamÃrez-Tortosa M.
Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancers. 2022; 14(21):5393.
https://doi.org/10.3390/cancers14215393
Chicago/Turabian Style
RamÃrez-Tortosa, César L., Rubén Alonso-Calderón, José MarÃa Gálvez-Navas, Cristina Pérez-RamÃrez, José Luis Quiles, Pedro Sánchez-Rovira, Alberto Jiménez-Morales, and MCarmen RamÃrez-Tortosa.
2022. "Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy" Cancers 14, no. 21: 5393.
https://doi.org/10.3390/cancers14215393
APA Style
RamÃrez-Tortosa, C. L., Alonso-Calderón, R., Gálvez-Navas, J. M., Pérez-RamÃrez, C., Quiles, J. L., Sánchez-Rovira, P., Jiménez-Morales, A., & RamÃrez-Tortosa, M.
(2022). Hypoxia-Inducible Factor-1 Alpha Expression Is Predictive of Pathological Complete Response in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancers, 14(21), 5393.
https://doi.org/10.3390/cancers14215393